Insights

Gathering insights about Tallac Therapeutics…

Similar companies to Tallac Therapeutics

Tallac Therapeutics Tech Stack

Tallac Therapeutics uses 8 technology products and services including WordPress Super Cache, Google Font API, Lodash, and more. Explore Tallac Therapeutics's tech stack below.

WordPress Super Cache
Caching
Google Font API
Font Scripts
Lodash
Javascript Libraries
Elementor
Page Builders
PHP
Programming Languages
Autoptimize
Web Platform Extensions
Apache HTTP Server
Web Servers
Apache
Web Servers

Media & News

Tallac Therapeutics's Email Address Formats

Tallac Therapeutics uses at least 2 format(s):

Tallac Therapeutics Email Formats	Example	Percentage
First@tallactx.com	John@tallactx.com	70%
FLast@tallactx.com	JDoe@tallactx.com	16%
Last@tallactx.com	Doe@tallactx.com	14%

Frequently Asked Questions

Where is Tallac Therapeutics's headquarters located?

Tallac Therapeutics's main headquarters is located at 866 Malcom Rd Suite 100 Burlingame, US. The company has employees across 2 continents, including North AmericaAsia.

What is Tallac Therapeutics's official website and social media links?

Tallac Therapeutics's official website is tallactherapeutics.com and has social profiles on LinkedIn.

How much revenue does Tallac Therapeutics generate?

As of September 2024, Tallac Therapeutics's annual revenue reached $3.8M.

What is Tallac Therapeutics's SIC code NAICS code?

Tallac Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tallac Therapeutics have currently?

As of September 2024, Tallac Therapeutics has approximately 21 employees across 2 continents, including North AmericaAsia. Key team members include Chief Medical Officer: K. N. H.Chief Business Officer: C. H.President, Chief Executive Officer And Co-Founder: H. I. W.. Explore Tallac Therapeutics's employee directory with LeadIQ.

What industry does Tallac Therapeutics belong to?

Tallac Therapeutics operates in the Biotechnology Research industry.

What technology does Tallac Therapeutics use?

Tallac Therapeutics's tech stack includes WordPress Super CacheGoogle Font APILodashElementorPHPAutoptimizeApache HTTP ServerApache.

What is Tallac Therapeutics's email format?

Tallac Therapeutics's email format typically follows the pattern of . Find more Tallac Therapeutics email formats with LeadIQ.

How much funding has Tallac Therapeutics raised to date?

As of September 2024, Tallac Therapeutics has raised $5M in funding. The last funding round occurred on Aug 02, 2023 for $5M.

Tallac Therapeutics

Biotechnology ResearchBurlingame, United States11-50 Employees

Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac’s pipeline of immunotherapy candidates are derived from the company’s novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a potent Toll-like receptor (TLR9) agonist (T-CpG) for targeted immune activation via systemic administration. Several TRAAC molecules are in various stages of discovery and preclinical development.

Company Overview

Headquarters: 866 Malcom Rd Suite 100 Burlingame, US
Website: tallactherapeutics.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 11-50

Media & News

Funding & Financials

$5M
Tallac Therapeutics has raised a total of $5M of funding over 3 rounds. Their latest funding round was raised on Aug 02, 2023 in the amount of $5M.
$10M
Tallac Therapeutics's revenue is in the range of $10M

Funding & Financials

$5M
Tallac Therapeutics has raised a total of $5M of funding over 3 rounds. Their latest funding round was raised on Aug 02, 2023 in the amount of $5M.
$10M
Tallac Therapeutics's revenue is in the range of $10M

Company Leadership

K. N. H.
Chief Medical Officer
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. H.
Chief Business Officer
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. I. W.
President, Chief Executive Officer And Co-Founder
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. Q. C.
Interim Chief Medical Officer
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. J. C.
Senior Director, Head Of Biology And Translational Research
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

P. S.
Vice President, Head Of Research
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. K.
Executive Director Of Biologics Development, Head Of Cmc
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. B.
Vice President, Clinical Sciences
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. S. 沈.
Vp Biologics Discovery And Development
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. H.
Vice President, Preclinical Development
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Tallac Therapeutics and Millions of Other Companies
Sign up for full access to Tallac Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Tallac Therapeutics

Sanofi

AstraZeneca

Novartis

Bristol Myers Squibb

Roche

Amgen

Merck

Biogen

Pfizer

AbbVie

Gilead Sciences

Johnson & Johnson

Genentech

Takeda

Tallac Therapeutics Tech Stack

Media & News

Tallac Therapeutics, Inc. receives financing of $15M in venture loan facility.

Tallac Therapeutics, Inc. hired Kevin N. Heller as chief medical officer on Jan 19th '23.

Tallac Therapeutics, Inc. launches Toll-like Receptor 9 Agonist Antibody Conjugate for Patients with Advanced Solid Tumors.

Tallac Therapeutics, Inc. is developing novel class of cancer immunotherapeutics on Mar 1st '21.

Benzinga - 21Shares AG partnered with Tallac Therapeutics, Inc. on Jan 10th '21.

Tallac Therapeutics, Inc. hired Curtis Hecht as Chief Business Officer on Apr 15th '21.

Selexis SA partners with Tallac Therapeutics, Inc..

Tallac Therapeutics's Email Address Formats

Frequently Asked Questions

Where is Tallac Therapeutics's headquarters located?

What is Tallac Therapeutics's official website and social media links?

How much revenue does Tallac Therapeutics generate?

What is Tallac Therapeutics's SIC code NAICS code?

How many employees does Tallac Therapeutics have currently?

What industry does Tallac Therapeutics belong to?

What technology does Tallac Therapeutics use?

What is Tallac Therapeutics's email format?

How much funding has Tallac Therapeutics raised to date?

Tallac Therapeutics

Company Overview

Media & News

Tallac Therapeutics, Inc. receives financing of $15M in venture loan facility.

Tallac Therapeutics, Inc. hired Kevin N. Heller as chief medical officer on Jan 19th '23.

Tallac Therapeutics, Inc. launches Toll-like Receptor 9 Agonist Antibody Conjugate for Patients with Advanced Solid Tumors.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?